Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ADALIMUMAB-ATTO vs ADAPALENE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ADALIMUMAB-ATTO vs ADAPALENE: Safety Overview

Metric ADALIMUMAB-ATTO ADAPALENE
Total FAERS Reports 1,146 181,442
Deaths Reported 7 6
Death Rate 0.6% 0.0%
Hospitalizations 68 68
Average Patient Age 53.7 yrs 24.3 yrs
% Female Patients 73.2% 78.5%
FDA Approval Date N/A Jan 14, 2022
Manufacturer N/A Galderma Laboratories, L.P.
Route N/A TOPICAL
Marketing Status Prescription Discontinued